Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy
Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro diagnostic use, designed for the qualitative detection and identification of Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes a and b of genotype 1 in human serum or EDTA plasma samples. Additional subtype information is available in a majority of cases.
“At Fujirebio we have been pioneering molecular testing solutions since the 1990’s with our high quality LiPA platform,” says Christiaan De Wilde, CEO at Fujirebio Europe. “The historical VERSANT HCV Genotype 2.0 Assay (LiPA) served as an efficient aid to personalized HCV therapy, and we are very pleased to maintain the availability of the test, now officially a part of our INNO-LiPA product range. We would like to extend our gratitude to all INNO-LiPA customers for their continued trust.”
About Hepatitis C virus
Hepatitis C virus is one of the leading causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma (primary liver cancer), resulting in major global public health concerns. The HCV infection is unevenly distributed worldwide, with variations in prevalence across and within countries.1
Globally, an estimated 50 million people have chronic hepatitis C virus infection, with about 1.0 million new infections occurring per year. WHO estimated that in 2022, approximately 242 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma. Early detection and treatment can prevent serious liver damage and improve long-term health.2
About INNO-LiPA HCV 2.0 Genotyping
INNO-LiPA HCV 2.0 Genotyping products are IVDR-marked. The available* products are:
- INNO-LiPA HCV 2.0 Genotyping <20T,CE> (Cat# 81547)
- INNO-LiPA HCV 2.0 Amp <20T,CE> (Cat# 81548)
- INNO-LiPA HCV 2.0 Control <3T,CE> (Cat# 81549)
- LiRAS® for LiPA HCV v4 <CE> (Cat# 15228)
The assay is available in a size of 20T. The test can be performed manually or automated (on the TENDIGO™ (Cat# 80412) instrument) and is not intended to be used as a screening test for HCV or as a diagnostic test to confirm the presence of HCV.
Visit www.fujirebio.com for more information about this product.
* Please contact Fujirebio for further information about the local availability of the test.
References:
- Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel MK, Razzack AA, Solimando AG, Thompson A, Andrews, K, Enebong Nya G, Ahmad S, Ranaldo R, Cozzolongo R, Shahini E. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):637-656. doi: 10.51821/84.4.015. PMID: 34965046.
- https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317463658/en/
Contacts
For media:
Public Relations Section, Public Relations/Sustainability Department,
H.U. Group Holdings, Inc..
Phone: +81-3-6279-0884
E-mail: pr@hugp.com
Christiaan De Wilde
CEO Fujirebio Europe
Phone: +32 9329 1703
For investors and analysts:
IR/SR Dept.
Phone: +81-3-5909-3337
E-mail: ir@hugp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetApp Storage Now Validated for NVIDIA DGX SuperPOD, NVIDIA Cloud Partners, and NVIDIA-Certified Systems18.3.2025 22:00:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that NVIDIA has validated high-performance NetApp enterprise storage systems with NetApp ONTAP® for environments powering AI training and inferencing. For the first time, with NetApp, customers can now get the benefits of validated configurations and architectures for NVIDIA—including NVIDIA DGX SuperPOD, NVIDIA Cloud Partners, and NVIDIA-Certified Storage—combined with the rich and mature data management services in NetApp ONTAP critical for building AI factories. These certifications ready NetApp to tap the NVIDIA AI Data Platform reference design for NetApp ONTAP to advance storage infrastructure with AI agents for reasoning model inference workloads, powered by NVIDIA accelerated computing, networking, and software. “NetApp and NVIDIA are longstanding technology partners, jointly serving hundreds of customers for AI model training and inferencing,” said Jonsi Stefansson, Senior Vice President and C
NetApp Fuels Future of Agentic AI Reasoning Solutions with NVIDIA AI Data Platform18.3.2025 22:00:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced it is advancing the state of the art in agentic AI with intelligent data infrastructure that taps the NVIDIA AI Data Platform reference design. By collaborating with NVIDIA, NetApp is enabling businesses to better leverage their data to fuel AI reasoning inference. In the era of intelligence, businesses need to rethink their data strategies to turn rapidly growing data estates into competitive assets that empower them to agilely navigate their business environment. By adopting an Intelligent Data Infrastructure framework, businesses will be able to operate under a unified vision that integrates metadata cataloging, automation, and hybrid cloud capabilities to eliminate siloes and deliver actionable insights at every stage of the AI pipeline. Together, NetApp ONTAP® and the NVIDIA AI Data Platform enable businesses to navigate the era of intelligence by building distributed systems that unlock the full
Outseer Launches Platformized Behavioral Biometrics Delivering Unmatched Defense in Depth18.3.2025 21:52:00 EET | Press release
Outseer, a recognized leader in authentication and fraud prevention for digital banking and 3-D Secure (3DS) transactions, announced its platform-native Behavioral Biometrics capability today. The addition of platformized Behavioral Biometrics introduces another layer of defense that continuously analyzes user interactions to detect anomalies in real time. Building on its rich RSA® heritage (formerly RSA Fraud & Risk Intelligence™), Outseer has enhanced its platform to meet today’s dynamic threat landscape. As fraud evolves—spurred by the digitization of payments, the spread of personal data across the dark web, the growing threat of scams and authorized fraud, as well as advancements like GenAI—Outseer’s multi-signal risk engine, leveraging sophisticated machine learning algorithms and AI, sets a new standard for continuous, unified protection. “Our customers are facing rising authorized and unauthorized fraud threats in digital banking and 3DS transactions, requiring fraud solutions
Ravenna Becomes the First Colourblind-Friendly City in Italy: Event and New EnChroma Glasses Donation18.3.2025 18:29:00 EET | Press release
Tomorrow, March 19, 2025, at 4:30 PM, the conference "How Colourblind People See" will be held at the Martini Hall of MAR – Ravenna’s Museum of Art. This event is dedicated to raising awareness about colour blindness and the challenges of colour perception. Speakers will include Stefano De Pietro, President of the Italian Association "How Colourblind People See", and Sandor Breznay, President of the Breznay-Ganoczy Foundation (Agno, Switzerland) and the Paolina Brugnatelli Foundation (Milan). Colour blindness affects approximately 1 in 12 men and 1 in 200 women, with over 300 million people worldwide experiencing this condition—2.5 million in Italy. While those with normal colour vision can distinguish over a million shades, individuals with colour vision deficiency see only about 10% of those hues. As a result, colours may appear dull or even indistinguishable. This initiative aims to increase public awareness and make cultural and educational experiences more accessible for those wit
Accelera hosts Spanish Prime Minister and industry leaders for tour and meeting at Guadalajara electrolyzer facility18.3.2025 18:10:00 EET | Press release
Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], hosted Spanish Prime Minister Pedro Sánchez and other government officials at its state-of-the-art electrolyzer manufacturing facility in Guadalajara, Castilla-la Mancha, Spain. The visit highlighted Accelera's important role in enabling the European Union (EU) and Spain's energy transition toward a sustainable future. Following Prime Minister Sánchez’s visit, Accelera held a meeting with top industry executives to explore opportunities for advancing the Spanish green hydrogen market together. The Government of Spain is committed to the green transition, with green hydrogen as one of its pillars. The decisive policies promoted by the Executive have allowed 20% of green hydrogen projects in Europe to be promoted in Spain. Prime Minister Sánchez toured the 260,000 square-foot proton exchange membrane (PEM) electrolyzer manufacturing facility, one of the largest in Spain, and met with Accelera employees
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom